Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches
European Journal of Cancer(2022)
Abstract
•Significant amount of relevant germline variants is detected by blood-tumour testing.•Carriers do not always fulfil clinical criteria for cancer predisposition.•Blood–Tumour testing identifies novel links between cancer predisposition genes and cancer types.•Family-specific screening strategies are required when cancer predisposition genes are found in atypical tumours.
MoreTranslated text
Key words
Next-generation sequencing,Tumour–normal testing,Precision oncology,Personalised medicine,Cancer predisposition syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined